End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.92 CNY | +0.30% | -4.62% | -8.40% |
Business Summary
Number of employees: 3,054
Sales per Business
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
98.3
%
| 3,187 | 97.5 % | 2,731 | 98.3 % | -14.31% |
Other Business
1.3
%
| 49 | 1.5 % | 36 | 1.3 % | -25.90% |
Real Estate
0.3
%
| 29 | 0.9 % | 9 | 0.3 % | -68.96% |
Building Materials
0.1
%
| 2 | 0.1 % | 2 | 0.1 % | -18.47% |
Sales per region
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
98.3
%
| 3,137 | 97.5 % | 2,696 | 98.3 % | -14.07% |
Abroad
1.7
%
| 81 | 2.5 % | 46 | 1.7 % | -43.23% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chun Sheng Leng
CEO | Chief Executive Officer | 50 | - |
Feng Qin Li
BRD | Director/Board Member | 64 | - |
Liping Gu
IRC | Investor Relations Contact | - | - |
Fan Su
SEC | Corporate Secretary | 45 | 20-06-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jun Ye Wang
CHM | Chairman | 59 | 20-09-27 |
Feng Qin Li
BRD | Director/Board Member | 64 | - |
Ya Ren An
BRD | Director/Board Member | 69 | - |
Chun Sheng Leng
CEO | Chief Executive Officer | 50 | - |
Ming Li He
BRD | Director/Board Member | 62 | - |
Dian Duo Wang
BRD | Director/Board Member | 66 | - |
Fu Bo Cao
BRD | Director/Board Member | 55 | - |
Wei Shi
BRD | Director/Board Member | 65 | - |
Yan Ming Wang
BRD | Director/Board Member | 56 | - |
Qing Xia He
BRD | Director/Board Member | 45 | 94-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,993,617,453 | 1,190,815,338 ( 59.73 %) | 0 | 59.73 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
65,200,114 | 16.03% | 533,964,158 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.40% | 2.72B | |
+0.44% | 90.78B | |
+9.61% | 43.96B | |
-16.67% | 31.34B | |
+44.99% | 23.45B | |
-9.42% | 16.48B | |
-25.92% | 15.03B | |
-9.27% | 12.79B | |
-7.57% | 12.19B | |
+0.07% | 8.5B |
- Stock
- Equities
- Stock Tonghua Dongbao Pharmaceutical Co., Ltd. - Shanghai S.E.
- Company Tonghua Dongbao Pharmaceutical Co., Ltd.